Patents Assigned to PEPVAX, INC.
  • Nucleic acid molecules and methods of using the same
    Patent number: 11844824
    Abstract: Nucleic acid molecules are provided herein that can be used, for example, to treat cancer or infections, or to induce an immune response in a subject, or to deliver or express a target molecule in or from a cell.
    Type: Grant
    Filed: March 6, 2019
    Date of Patent: December 19, 2023
    Assignee: PEPVAX, INC.
    Inventors: Mahesh Narayanan, Anton Dormer